Gastroenterology Doctors in Natick, MA Accepting Medicare

2 Gastroenterology doctors found. Showing 1 - 2

Dr. Lawrence Handler, M.D. Internal Medicine - Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 67 Union St, Suite 201, Natick, MA 01760 Phone: 508-651-1998    Fax: 508-651-2587

Dr. Frank R Malkin, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 67 Union St, Suite 105, Natick, MA 01760 Phone: 508-650-9965    Fax: 508-655-0397

News Archive

Scientists identify possible therapeutic strategy for reducing leukemia risk from chemotherapy

A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia. Their finding also may explain, they say, why some other age-related hematological disorders develop.The study, reported in "Cell Stem Cell" and reviewed in Cell Stem Cell and Cell, opens a new frontier for studying the molecular underpinnings of adult leukemia.

African American men have fewer, less severe coronary obstructions than white males

While African American men are more likely to die from cardiovascular disease, they paradoxically have fewer cases of coronary obstruction than clinically similar white men, according to a new national study led by a Medical College of Wisconsin researcher.

Lowfat or fat free milk daily can help maintain healthy weight

Now there's a new reason to grab a glass of milk when you're on diet, suggests a new study published in the American Journal of Clinical Nutrition. In a 2-year weight loss study, milk drinkers had an advantage over those who skipped the milk. Israeli researchers found that adults who drank the most milk (nearly 2 glasses per day) and had the highest vitamin D levels at 6 months, lost more weight after 2 years than those who had little or no milk or milk products nearly 12 pounds weight loss, on average.

Novel FAK inhibitors targeting binding site of VEGFR-3 reduce growth of pancreatic cancer cells

CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.

Breast cancer survivors should get regular exercise to enjoy high quality of life

Older women who have overcome breast cancer are likely to struggle with heart disease, osteoporosis and hypertension further on in their lives. Whether these conditions occur or not is influenced by the treatment that patients received to fight cancer, their overall weight and their age.

Read more Medical News

› Verified 2 days ago